1. Home
  2. VRTX vs HOOD Comparison

VRTX vs HOOD Comparison

Compare VRTX & HOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRTX
  • HOOD
  • Stock Information
  • Founded
  • VRTX 1989
  • HOOD 2013
  • Country
  • VRTX United States
  • HOOD United States
  • Employees
  • VRTX N/A
  • HOOD N/A
  • Industry
  • VRTX EDP Services
  • HOOD Computer Software: Prepackaged Software
  • Sector
  • VRTX Technology
  • HOOD Technology
  • Exchange
  • VRTX Nasdaq
  • HOOD Nasdaq
  • Market Cap
  • VRTX 115.6B
  • HOOD 102.2B
  • IPO Year
  • VRTX 1991
  • HOOD 2021
  • Fundamental
  • Price
  • VRTX $398.10
  • HOOD $109.66
  • Analyst Decision
  • VRTX Buy
  • HOOD Buy
  • Analyst Count
  • VRTX 24
  • HOOD 22
  • Target Price
  • VRTX $496.76
  • HOOD $97.50
  • AVG Volume (30 Days)
  • VRTX 2.5M
  • HOOD 41.7M
  • Earning Date
  • VRTX 08-04-2025
  • HOOD 07-30-2025
  • Dividend Yield
  • VRTX N/A
  • HOOD N/A
  • EPS Growth
  • VRTX N/A
  • HOOD 513.62
  • EPS
  • VRTX 14.07
  • HOOD 1.96
  • Revenue
  • VRTX $11,418,800,000.00
  • HOOD $3,567,000,000.00
  • Revenue This Year
  • VRTX $10.40
  • HOOD $30.33
  • Revenue Next Year
  • VRTX $10.63
  • HOOD $18.88
  • P/E Ratio
  • VRTX $28.24
  • HOOD $54.10
  • Revenue Growth
  • VRTX 10.46
  • HOOD 59.38
  • 52 Week Low
  • VRTX $362.50
  • HOOD $18.71
  • 52 Week High
  • VRTX $519.88
  • HOOD $117.70
  • Technical
  • Relative Strength Index (RSI)
  • VRTX 43.02
  • HOOD 50.16
  • Support Level
  • VRTX $388.93
  • HOOD $99.00
  • Resistance Level
  • VRTX $400.94
  • HOOD $108.21
  • Average True Range (ATR)
  • VRTX 12.48
  • HOOD 5.70
  • MACD
  • VRTX 1.47
  • HOOD -1.42
  • Stochastic Oscillator
  • VRTX 72.97
  • HOOD 34.33

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About HOOD Robinhood Markets Inc.

Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.

Share on Social Networks: